Return to Play Checklist

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Labral Tear, Glenoid Clinical Trial

Official title:
Safe Return to Play Following Surgery for Labral Repair: Development and Validation of a Return to Play Checklist

Status Enrolling by invitation

Clinical Trial Summary

This study will try to develop and determine objective and validated criteria for our athletes to safely return to sports after labral repair.

n/a

NCT number	NCT04278716
Study type	Observational
Source	Rothman Institute Orthopaedics
Contact
Status	Enrolling by invitation
Phase
Start date	May 14, 2018
Completion date	June 2021

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04094701` - Hip Arthroscopy Postoperative Opioid Demands	N/A
Terminated	`NCT04093700` - MDR SureLock All-Suture Anchor
Enrolling by invitation	`NCT05974423` - Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair	Phase 4
Recruiting	`NCT04113759` - Blood Flow Restriction Following Hip Arthroscopy	N/A
Active, not recruiting	`NCT03985839` - Safety and Performance of MICRORAPTOR™ Suture Anchors in Shoulder and Hip
Not yet recruiting	`NCT06043791` - Applicability of 3T Shoulder MRI in Detection of Labral Pathology	N/A